La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Shimadzu Bilan de santé

Santé financière contrôle des critères 6/6

Shimadzu possède un total de capitaux propres de ¥499.9B et une dette totale de ¥1.6B, ce qui porte son ratio d'endettement à 0.3%. Son actif total et son passif total sont ¥664.9B et de ¥165.0B. L'EBIT de Shimadzu est ¥70.5B ce qui fait que son ratio de couverture des intérêts -51.9. Elle dispose de liquidités et de placements à court terme de ¥150.4B.

Informations clés

0.3%

Ratio d'endettement

JP¥1.59b

Dette

Ratio de couverture des intérêts	-51.9x
Argent liquide	JP¥150.37b
Fonds propres	JP¥499.93b
Total du passif	JP¥164.96b
Total des actifs	JP¥664.89b

Mises à jour récentes de la santé financière

Does Shimadzu (TSE:7701) Have A Healthy Balance Sheet?

Apr 29

Recent updates

The Shimadzu Corporation (TSE:7701) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Aug 10

Shimadzu's (TSE:7701) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 03

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 7701 ( ¥452.7B ) dépassent ses passifs à court terme ( ¥141.4B ).

Passif à long terme: Les actifs à court terme de 7701 ( ¥452.7B ) dépassent ses passifs à long terme ( ¥23.5B ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: 7701 dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Le ratio d'endettement de 7701 a été réduit de 0.8% à 0.3% au cours des 5 dernières années.

Couverture de la dette: La dette de 7701 est bien couverte par le flux de trésorerie opérationnel ( 1893.6% ).

Couverture des intérêts: 7701 gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.

Shimadzu Bilan de santé

Santé financière contrôle des critères 6/6

Informations clés

Mises à jour récentes de la santé financière

Does Shimadzu (TSE:7701) Have A Healthy Balance Sheet?

Recent updates

The Shimadzu Corporation (TSE:7701) First-Quarter Results Are Out And Analysts Have Published New Forecasts

First quarter 2025 earnings released: EPS: JP¥33.89 (vs JP¥37.67 in 1Q 2024)

Now 21% overvalued after recent price rise

Calculating The Fair Value Of Shimadzu Corporation (TSE:7701)

Shimadzu (TSE:7701) Is Due To Pay A Dividend Of ¥26.00

Shimadzu (TSE:7701) Is Due To Pay A Dividend Of ¥26.00

Final dividend of JP¥26.00 announced

Shimadzu Corporation's (TSE:7701) Price Is Out Of Tune With Earnings

Shimadzu Corporation to Report Q1, 2025 Results on Aug 07, 2024

Now 22% overvalued after recent price rise

Full year 2024 earnings: EPS exceeds analyst expectations

Shimadzu Corporation, Annual General Meeting, Jun 26, 2024

Shimadzu Corporation (TSE:7701) announces an Equity Buyback for 12,500,000 shares, representing 4.24% for ¥25,000 million.

Does Shimadzu (TSE:7701) Have A Healthy Balance Sheet?

Calculating The Intrinsic Value Of Shimadzu Corporation (TSE:7701)

Upcoming dividend of JP¥34.00 per share

Shimadzu's (TSE:7701) Shareholders Will Receive A Bigger Dividend Than Last Year

Shimadzu Corporation to Report Fiscal Year 2024 Results on May 10, 2024

Now 21% overvalued after recent price rise

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Shimadzu Corporation to Report Q3, 2024 Results on Feb 06, 2024

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Upcoming dividend of JP¥23.00 per share at 1.3% yield

Shimadzu Corporation to Report Q2, 2024 Results on Nov 07, 2023

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Shimadzu Corporation (TSE:7701) acquired Biomaneo.

Shimadzu Corporation to Report Q1, 2024 Results on Aug 04, 2023

Shimadzu Corporation, Annual General Meeting, Jun 28, 2023

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Upcoming dividend of JP¥28.00 per share at 1.2% yield

Third quarter 2023 earnings: EPS misses analyst expectations

Shimadzu Corporation to Report Nine Months, 2023 Results on Feb 06, 2023

High number of new directors

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Upcoming dividend of JP¥22.00 per share

Shimadzu Corporation to Report First Half, 2023 Results on Nov 07, 2022

First quarter 2023 earnings: EPS misses analyst expectations

Shimadzu Corporation to Report Q1, 2023 Results on Aug 05, 2022

Shimadzu Corporation, Annual General Meeting, Jun 28, 2022

Full year 2022 earnings: EPS exceeds analyst expectations

Less than half of directors are independent

Shimadzu Corporation to Report Fiscal Year 2022 Results on May 10, 2022

Upcoming dividend of JP¥21.00 per share

Rakuten Medical, Inc. and Shimadzu Corporation Enrolls First Patient in the U.S. Clinical Trial of Photoimmunotherapy

Third quarter 2022 earnings: EPS exceeds analyst expectations

Second quarter 2022 earnings released: EPS JP¥39.91 (vs JP¥33.11 in 2Q 2021)

Upcoming dividend of JP¥17.00 per share

First quarter 2022 earnings released: EPS JP¥29.62 (vs JP¥14.12 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥123 (vs JP¥108 in FY 2020)

Upcoming dividend of JP¥15.00 per share

New 90-day high: JP¥4,340

Third quarter 2021 earnings released: EPS JP¥32.90 (vs JP¥27.62 in 3Q 2020)

Revenue and earnings beat expectations

Price target raised to JP¥4,305

New 90-day high: JP¥4,150

Price target raised to JP¥4,021

New 90-day high: JP¥3,910

Shimadzu Corporation to Report Q3, 2021 Results on Feb 05, 2021

New 90-day high: JP¥3,840

Shimadzu Corporation and RIKEN Innovation Co., Ltd Enters into Agreement to Jointly Start R&D Program

Shimadzu Corporation to Report Q2, 2021 Results on Nov 09, 2020

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines